Bacteria offer resistance to a broad range of antibiotics by activating their export channels of ATP-binding cassette transporters. These transporters perform a central role in vital processes of self-immunity, antibiotic transport and resistance. The majority of ATP-binding cassette transporters are capable of detecting the presence of antibiotics in an external vicinity and are tightly regulated by two-component systems. The presence of an extracellular loop and an adjacent location of both the transporter and two-component system offers serious assistance to induce a quick and specific response against antibiotics. Both systems have demonstrated their ability of sensing such agents, however, the exact mechanism is not yet fully established. This review highlighted the three key functions of antibiotic resistance, transport and self-immunity of ATP-binding cassette transporters and an adjacent two-component regulatory system.
Introduction
Bacterial resistance to antimicrobial agents is a global concern in the treatment of bacterial infections. Bacteria have developed various mechanisms to overcome all such agents meant to kill them. Most of these agents, such as antimicrobial peptides (AMPs), attack the bacterial cell surface and challenge their cellular integrity. In contrast, bacteria adopt approaches to limit AMPs and cell-surface interactions. A bacterium utilizes a number of strategies in the form of various enzymes, efflux pumps and equipped plasmids to defend itself or to develop resistance to different kinds of agents, like antibiotics. These strategies are induced in response to AMPs, allowing bacteria to inhibit their functions. These resistive approaches may evolve within a bacterial lineage or genetically acquired from other AMP-resistant organisms. Both the Gram-negative and Gram-positive bacteria retain such abilities to counter the incoming foreign agents [1] Published reviews have covered bacterial resistance mechanisms, the biosynthesis of antimicrobial compounds, selfimmunity, transport, mode of action and classification of ABC transporters [2] [3] [4] [5] [6] . However, previous reviews did not summarize specifically the role of two-component systems (TCSs) and their cognate ATP-binding cassette (ABC) transporters in three different related processes. This review aims to highlight the interplay between ABC transporters and their specific TCSs in antimicrobial drug resistance, production and self-immunity or self-resistance. Their significant role in these mechanisms makes them favourable candidates for further research in the field of antibiotic resistance, in particular, and its production, in general.
targets of antimicrobial agents
Antibiotics are classified according to their nature, mode of action and mechanism. The majority of antibiotics are designed to target different locations to control bacterial growth through different mechanisms depending on their class (Table 1) . β-lactam drugs such as penicillin, cephalosporin, carbapenem and monobactam attack and interfere with the bacterial cell wall and suppress their growth by inhibiting key enzymes required for the synthesis of the cell wall or peptidoglycan layer. Glycopeptides like vancomycin and teicoplanin, target d-alanine residues of peptidoglycan chain to prevent cross-linking and affect cell-wall stability. Aminoglycosides, macrolides, chloramphenicol, streptogramins, tetracycline and oxazolidinones target bacterial protein synthesis and retard growth. Some antimicrobial compounds, like fluoroquinolones, disrupt DNA replication, while others, including sulfonamides and trimethoprim, inhibit the folic acid synthesis pathway by indirectly blocking DNA synthesis [2, 7] .
Resistance to antimicrobial agents
Bacteria possess innate and acquired resistances against antimicrobial agents. In innate resistance, bacteria harbour resistance to a particular class of antimicrobial agent. However, acquired resistance is developed in certain strains of susceptible bacteria and may retain the ability to proliferate under the same selective pressure [8] . To gain the acquired resistance, bacteria undergo several changes in their metabolic pathways through mutation or horizontal gene transfer. Some bacteria alter penicillin-binding sites and prevent substrate binding by modifying their proteins such as penicillin-binding protein 2a (PBP2a) encoded by evolved genes mecA [7] . PBP2a decreases affinity for β-lactam antibiotics and continues to cross-link the cell wall once the native PBPs (i.e. PBPs 1 to 4) have been inactivated [9] [10] [11] [12] . Bacteria also defend themselves by varying cell-wall charges as in cationic AMP resistance, positively charged residues are incorporated to the cell envelope, which increases the net positive charge on the cell surface and repel cationic AMPs [13] . In Bacillus subtilis bacitracin resistance is mediated by a phosphatase BcrC that degrades C 55 -PP to C 55 -P on the periplasmic surface and prevents recognition of bacitracin [14] . Some bacteria use TCS-regulated efflux pumps to remove the antimicrobial agent from the cell and confer resistance longterm [13] . In recent years, the prevalence of superbugs has been established that harbour one or both plasmid-encoded genes ndm1 and mcr1 and retain the ability to hydrolyse the β-lactam ring of the antibiotic and inactivate them. The later one targets the last resort colistin effectively. The ndm1 codes for β-lactamases, a bi/mono zinc-containing enzyme in the active site and belong to the metalo-lactamase family of the proteins [15, 16] .
Bacterial ABC transporters and tCs
ABC transporters are an important class of related proteins performing transportation of substrates, including peptides, amino acids, sugars and antibiotics [17] [18] [19] [20] . Typically, proteins of this family transport substrates across the cell membrane, including the elimination of waste products and antibiotics. ABC transporters have been discovered in various organisms, e.g. 28 in Saccharomyces, 58 in Caenorhabditis, 51 in Drosophila, 129 in Arabidopsis and 69 in Escherichia. Approximately 5 % B. subtilis and Escherichia coli genome encode components of ABC transporters [21] . ABC transporters comprise a conserved ATPase domain, termed as a nucleotide-binding domain (NBD) and a hydrophobic domain, known as the permease domain or membrane-spanning domain (MSD). The NBD domain contains conserved motifs, walker A, walker B and a signature sequence. Three other conserved loops found in NBD domains are named Q, D and H [22, 23] . This domain binds and hydrolyses ATP to provide energy for the import and export of a broad range of substrates [24] . The permease domain acts as a channel route for substrate transport across the membrane.
On the basis of permease domain architecture, ABC transporters related to AMP antibiotic transport are comprehensively classified into five different groups SunT, NisT, LanFEG, BcrAB and BceAB. The BceAB family constitutes ten transmembrane helices and is unique due to the presence of a large unconventional extracellular (EC) loop of about 200 residues between helix 7 and 8 [25, 26] . These groups of ABC transporters are involved in various aspects of transportation mechanisms. The LanFEG is actively involved in self-resistance in antibiotic producing bacteria, whereas the BceAB group of transporters are involved in external resistance [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] . LanT actively participates in the transport of peptide antibiotics once they are produced [38] .
However, based on overall structural fold, to date seven groups of ABC transporters are classified into type I to VII. The functional details of these seven types have been recently discussed by Greene et al. [39] . AMPs or lantibiotics, like bacitracin and nisin, are post-translationally modified peptides and are [40] . Mostly the activities of these transporters are regulated by the TCS of bacteria, which are the major cell signalling and transcriptional regulation system in prokaryotic cells. A typical TCS contains a membrane-integrated sensor histidine kinase (SK/HK) [41] , which senses and interprets a stimulus, and activates a cytoplasmic response regulator (RR). The output executes changes that alters the expression of a specific set of genes [42] . SK and RR communicate through conserved phosphorylation of histidine and aspartate residues [43, 44] . TCSs have the ability to sense diverse signals through the EC sensing loop, which varies in length. In B. subtilis, the BceS and YvcQ N-terminal transmembrane helices are connected with an EC loop of about 2-10 residues, which are almost buried inside the cytoplasmic membrane. With such a short EC sensing loop, SKs may sense the external stimuli at the cytoplasmic surface or directly inside the membrane (Fig. 1) . A kinase family having such an SK of a TCS was named intermembrane sensing kinases (IMSK) [45, 46] . How IMSKs sense their stimuli still needs to be investigated but it is reported that IMSKs are assisted by ABC transporters encoded adjacent to the corresponding TCS in a different operon [47] . These adjacent TCSs are able to regulate the expression of ABC transporters [41, 45, [47] [48] [49] [50] [51] . An external substrate such as bacitracin can be sensed by a large EC loop of these transporters [52] . It is assumed that external stimuli in the form of antibiotics can be sensed by either the short sensing loop of IMSK or large EC loop of the permease domain of the transporter [45, 51, 52] .
In Gram-positive bacteria, ribosomal-encoded peptides with antimicrobial activities are transported to the external environment, which develops self-resistance/immunity from their own products [3, 31, 38, 53] . Such bacteria pose an autoimmune mechanism in the form of immunity protein and ABC transporters [54] . These organisms are active against other bacteria that belong to the same species or across genera [24] . Pathogenic bacteria-producing AMPs are becoming a potential threat by presenting enormous resistance to various kinds of available antibiotics [29, 51, 55, 56] .
Antibiotic resistance mediated by ABC transporters and tCs

Bacillus subtilis
Most Gram-positive bacteria contain antibiotic sensing and detoxification systems in the form of genetically linked TCS and ABC transporters [57] [58] [59] . B. subtilis is equipped with three kinds of such sensing and detoxification systems, BceRS-BceAB, YvcPQ-YvcRS (now PsdRS-PsdAB) and YxdJK-YxdLM. All the three SKs of the TCS, BceS, PsdS and YxdJ belong to the IMSK family of histidine kinases. In B. subtilis the BceRS-BceAB has been established in mediating bacitracin resistance but this system has also shown a response to fungal defensin, plectasin, gardimycin, actagardine and mersacidin [28, 41, 60] . The presence of bacitracin induces BceRS and PsdRS TCS along with BceAB and PstAB ABC transporters. The bceRS genes are located immediately upstream of the bceAB operon, which senses extracellular bacitracin and regulates bceAB expression. DNAse-I foot-printing and bceAB promoter deletion experiments have shown that BceS responds to extracellular bacitracin and regulates bceAB expression by its cognate RR BceR. The BceR directly regulates bceAB expression by binding to the upstream region of the bceAB promoter. The bceAB disruption mutants showed hypersensitivity to bacitracin suggesting the importance of BceAB in bacitracin resistance [28, 41] . The DNA-binding site for the BceR RR has been identified in the upstream region of BceA, which consists of an inverted repeated sequence with internal spacer (GTGTGACG-N4-TGTCACAT) (Fig. 2) . The length of the spacer region and inverted repeats suggested that BceR interacts as a dimer with successive major grooves of DNA helix on the same face ( Fig. 2 ) [41, 47, 61] .
This regulation is highly sensitive and can render resistance to 0.03 µg ml −1 concentration of bacitracin [52] . Besides bacitracin, other antibiotics like actagardine and mersacidin have shown the induction of BceAB transporter whereas mersacidin induction is at a similar level to bacitracin [62] . The mechanism behind antibiotic sensing is not well understood, though in the case of bacitracin its recognition by the BceRS-BceAB system is reported by numerous studies and the BceRS-BceAB system is ranked by a specific module to bacitracin resistance. However, it can also be induced by a diverse class of compounds causing cell-wall stresses [60, 62] .
The MSD of BceB exhibits an EC loop of >170 amino acids and is required to sense bacitracin followed by induction of BceAB transporter [18, 20, 52] . Apart from BceB (MSD), BceA (NBD) has also shown effects for bacitracin sensing. Generally, the BceA domain has two activities, ATP-binding followed by substrate hydrolysis. Two allelic mutations, G40A and K46A, in walker A motifs have been shown to block the ATP-binding activity of NBD and resulted in the failure to sense bacitracin. Another mutation E169Q in walker B only abrogated its substrate hydrolysis and hinders bacitracin sensing by BceA, suggesting an ATP-driven process [52] .
Another TCS, PsdRS regulates the adjacent downstream transporter genes psdAB and acts as an alarm for the presence of antibiotics [60] . Initially, the PsdRS-AB system was considered part of the bacitracin resistance network [28, 41] because a mutant bceAB strain failed to induce psdR [52] . Currently, this system is recognized as a sensitive system to lipid-II-binding peptide antibiotics, including nisin, subtilin, actagardine, gallidermin and enduracidin. Interestingly, actagardine and mersacidin are structurally similar lipid-IIbinding peptide antibiotics but the latter does not induce the PsdRS-AB system, indicating its sensing specificity. Such a kind of recognition of the Psd system is not limited to AMPs but can also recognize different structurally related peptides, i.e. ramoplanin and enduracidin. It has been suggested that these systems recognize peptide antibiotics from their N-terminal region rather from the whole structure [63] . The induction of pstRS TCS along with its adjacent ABC transporter against lipid-II-binding peptide enduracidin has been suggested by a DNA microarray study [60, 64] . How the PsdRS-AB system differentiates between structurally similar compounds is yet to be elucidated. It is speculated that the AMPs are sensed by the PsdSR TCS that in turn induces the PstAB transporter in mediating resistance. The PsdR-binding site is located at position −99 to −70 upstream to pstA and consists of imperfect inverted repeats with a 4 nucleotide spacer region (ATGTGACA-N4-TGTAAGAT) (Fig. 2) [60, 61] . The third system in Bacillus is YxdJK-LM that mediates resistance to human AMP LL-37, an AMP produced by human neutrophils when active against Gram-positive and Gramnegative bacteria [65] . It seems unlikely that the YxdJK-LM system is active against LL-37 as B. subtilis is a soil bacterium. However, there is a possibility that LL-37 resembles some unknown natural peptide antibiotic stress and therefore the system is able to respond. In B. subtilis, ytpB expresses a C 35 -PP utilizing enzyme to synthesize sesquarterpenoids. Inactivation of ytpB results in elevated sensitivity to bacitracin suggesting an accumulating factor of C35-PP rather than the absence of sesquarterpenoids. In a bceAB bcrC double mutant, disruption of ytpB no longer increases bacitracin sensitivity. These results suggest that C 35 -PP inhibits both BcrC (a C 55 -PP phosphatase) and BceAB (an ABC transporter that confers bacitracin resistance). These findings lead to a model in which BceAB protects against bacitracin by transfer of the target, C 55 -PP, rather than the antibiotic across the membrane. In a B. subtilis double mutant bceAB and bcrC (a C 55 -PP phosphatase), ytpB no longer has increased bacitracin sensitivity, suggesting that C 35 -PP inhibits both the BcrC and BceAB transporter to confer bacitracin resistance. These results suggest that BceAB increases resistance against bacitracin through transfer of a target C 55 -PP rather than to transport it outside [66] .
Staphylococcus aureus
S. aureus is a human pathogen that shows resistance to a variety of therapeutic agents like β-lactams, quinolones, aminoglycosides and bacitracin [67] [68] [69] . The treatment of Staphylococcal infections is gradually becoming a challenge due to immense antibiotic resistance [70] . The S. aureus genome has 16 sets of TCS genes, with an additional one present in the staphylococcal cassette chromosome mec element of methicillinresistant S. aureus strains [71] . Among these TCSs, several kinds have been identified, affecting susceptibility to several antibiotics [12, 50] . For instance, VraSR TCS was shown to be responsible for resistance to cell-wall-damaging compounds, including β-lactam antibiotics and some cationic AMPs [72] , whereas the up-regulation of GraRS TCS has been reported leading to glycopeptide resistance [41] .
The GraRS TCS in S. aureus are the homologues of B. subtilis BceRS [73] . This TCS in S. aureus regulates the expression of its cognate downstream ABC transporter encoded by vraFG. Genes of the GraRS TCS and VraFG ABC transporter are transcribed in individual operons whereas VraF and VraG encode a putative ATPase and permease components of the transporter, respectively [50, 74] . In S. aureus the main pathway responsible for cationic AMPs (bacteriocin) is regulated by GraRS TCS [75, 76] . In addition, mutations in graRS or its adjacent ABC transporter genes vraFG, render the bacterial strain hyper-susceptible to polymyxin B (PMB; a cyclic cationic bacterium-derived peptide) [50] . Apart from vraFG, the GraRS TCS also regulates the expression of mprF and dltABCD operon [49, 75] . It is noteworthy to mention that the dltABCD operon contributes to the net positive surface charge by covalently incorporating d-alanine to the cell wall's teichoic acids whereas MprF adds positively charged lysine residues to phosphatidyl glycerol within the cell membrane of S. aureus (Fig. 3) [77] [78] [79] [80] . To induce the expression of mprF and dltABCD operon, the GraRS TCS is assisted by the VraFG transporter. A vraG mutant strain failed to induce the expression of MprF and DltABCD operon in the presence of PMB, suggests that cationic AMPs are sensed by GraSR and in turn regulates mprF and dltABCD operon through the VrdG transporter. The mechanism does not make it clear how the VraG ABC transporter assists GraRS in the regulation of mprF and dlt operon [49, 50, 81] . The mprF and dltABCD increase the positive charge of the outer membrane whereas the VraFG transporter may possibly remove the cationic AMPs from the membrane (Fig. 3) . A novel accessory protein GraX/AspX (a potential epimerase) has been identified that is translated by the operon GraRS, and is believed to be a helpful candidate in resistance [81] . A study has identified the presence of conserved ten base pair palindromic sequences (5′-ACAAATTTGT-3′) located upstream of vraFG operon and 29 other potential GraR regulon members in S. aureus [70] .
Cell-wall thickening was observed in a vancomycin-resistant S. aureus (VRSA) strain. In VRSA strains two different studies have reported overexpression of VraRS TCS along with putative ABC transporter VraDE in response to cationic AMPs, temporin L, ovispirin L and dermaseptin [72, 81] . It is believed that VraSR TCS is a general TCS of S. aureus and can sense general cell-wall damage or stresses because the system has the ability to induce many cell-wall active agents including antibiotics, for example, cephalosporin, vancomycin, daptomycin, chlorpromazine, cefotaxime, sodium tungstate, oxacillin, ceftobiprole, EGTA, phenothiazine, ovisprin-1-NH2, temporin-l-NH2, teicoplanin and bacitracin [49, [81] [82] [83] .
ABC transporter VraDE is similar to the BceAB bacitracin transport system of B. subtilis [67, 78] , where its role has been reported in resistance to bacitracin and is involved as a bacitracin detoxification pump. The role of VraDE in resistance to various antibiotics was reported but few consecutive studies described its role limited to nisin and bacitracin resistance [64, 81, 84] . Previously, it was stated that vraDE is in control of GraRS TCS in response to indolicidin. Threefold expression of VraDE instead of nine in the case of mutant GraRS indicated the presence of some other system [49] . Later, the VraDE expression was tested in the presence of indolicidin concentration (0.5-40 μg ml −1 l) and resulted in zero induction. Consistently, in addition to indolicidin, bacitracin, nisin and colistin were investigated for the VraDE induction in the wild-type and GraRS mutant, which failed to identify VraDE in the GraRS regulon [84] . In the light of recent reports, it seems likely that the VraDE transporter in the sensory complex with TCS performs a dual role of sensing and detoxification [85] .
A novel TCS BraRS (also called BceRS) in S. aureus for bacitracin sensing and detoxification has been characterized. The BraRS TCS in S. aureus is located upstream of ABC transporter BraDE (also called BceAB) in a separate transcriptional operon. The BraRS activates transcription of the two ABC transporters BraDE and VraDE (Fig. 3) . In the case of bacitracin and nisin, BraDE is involved in sensing while VraDE acts specifically as a detoxifying module [64, 84] . The BraRS TCS was tested for substrate specificity against different compounds, including bacitracin, vancomycin, daptomycin and nisin and suggested a role for BraRS in bacitracin and nisin resistance [45] . A mechanistic model postulates the sensing of external stimuli by the EC loop of TCS but BraS belongs to the IMSK family of proteins and its EC loop contained only three residues [45] . A new model has been proposed that the antibiotics are first detected by the BraDE transporter encoded adjacent to the BraRS TCS. A braDE mutant fails to sense bacitracin or nisin in the presence of BraRS TCS. Once the stimuli are sensed the BraRS induces the expression of its regulon including vraDE for detoxification. The 14 base pair conserved palindromic motif with a spacer region (CTTTCAA-NN-T/CTGTAAG) was identified, located 66 and 64 bp upstream from the braDE and vraDE transcription start sites suggest that both BraDE and VraDE transporters are regulated by the same TCS BraRS [84] .
Streptococcus mutans
S. mutans, the causative agent of human dental caries is a pathogenic Gram-positive bacterium resisting bacitracin [19, 86, 87] . The bacitracin resistance property of the bacteria has attributed to four ORFs, mbrA, mbrB, mbrC and mbrD located adjacent to each other with intergenic regions of −8, 41 and −4 bp, respectively. MbrA and MbrB constitute ATPase and permease domain of ABC transporter followed by the MbrCD TCS [19, 88, 89] . All the four genes mbrABCD constitute a single operon [51] , however, only the mRNA level of mbrAB showed a significant increase in response to bacitracin induction indicates a possible two operon system [89] . Upon activation the RR MbrC binds to the promoter region located −120 and −78 bp upstream and regulates the expression of mbrABCD operon. The regulation of all four genes in an operon by MbrC indicates a possible auto regulatory circuit in the presence of bacitracin. The mutant D54N MbrC and an mbrCD TCS knockout strain failed to induce the ABC transporter mbrA and mbrB in the presence of extracellular bacitracin. Further, the strain lacking either domain of the ABC transporter (MbrA or MbrB) remained unable to sense bacitracin. Besides, the human α-and β-defensin induced the expression of mbrABCD in a similar fashion as bacitracin did, which was distinguishable from nisin, vancomycin, penicillin-G and lysozyme. All the mutans exhibiting ΔmbrA, ΔmbrB, ΔmbrC and ΔmbrD were found more sensitive to human α-and β-defensin than the parent strain [51, 89] .
Overall, the MbrAB transporter seems a necessary candidate to sense bacitracin in the environment and is regulated by its adjacent MbrCD TCS.
Streptococcus pneumoniae
ABC transporter genes make up a significant portion of bacterial genomes including S. pneumoniae and their role in resistance to various kinds of antibiotics has been identified in different strains [90] . The analysis of transcriptional stress response of S. pneumoniae strain D39 to structurally different AMPs nisin, bacitracin and LL-37 have shown that the genes of ABC transporters and TCS SP0912-0913, SP0785-0787, SP0386-0387 are involved in AMP resistance. Putative ABC transporter SP0912-0913 genes contributed to resistance by up-regulating the expression against bacitracin, nisin, gramicidin, lincomycin, LL-37 and vancomycin [29, 91] . The reduced susceptibility to vancoresmycin and intrinsic resistance to bacitracin are reported for an ABC transporter encoded by spr0812-0813 in strain R6. A non-sense mutation spr0813 C1744T (encodes a C-terminal truncated Spr0813 Q582* permease of ABC transporter) lacking 81 amino acids and 2 C-terminal transmembrane domains, contributed to reduced susceptibility against vancoresmycin and bacitracin in S. pneumoniae strain R6 suggested that the disruption of C-terminus transmembrane helices may lead to altered substrate specificity of the permease domain [55] . The homologues of SP0912-0913, bceAB of B. subtilis, mbrAB of S. mutans and ysaBC of L. lactis also showed their induction against LL-37, bacitracin, lincomycin and nisin challenge [19, 92, 93] . In S. pneumoniae D39, SP0386-0387 encoding TCS03 along with its upstream adjacent gene SP0385 (encoding a putative membrane protein) are reported to be up-regulated against bacitracin and LL-37. TCS03 and its upstream gene SP0385 mutant increased sensitivity of D39 strain to bacitracin by twofold. SP0385 shares sequence identity of 27 % to LiaF (YvqF) a member of LiaRS gene cluster [29] . The mutation of YvqF resulted in overexpression of VraRS TCS and showed enhanced resistance to teicoplanin and vancomycin in S. aureus [94] . [98] .
Lactococcus lactis
Nisin, a lipid-II-peptide antibiotic is produced by L. lactis. The ABC transporter genes ysaBC are located on ysaBCD operon and expressed at tenfold levels in nisin resistance of L. lactis [76, 99] . The orthologues of YsaBC were identified in S. mutans (MbrBA), S. pneumoniae (SP0913-12) and B. subtilis (BceAB). YsaB and YsaC are the respective permease and ATPase domains of the transporter [19, 45] . Previously, it is also suggested that YsaBC may involve in nisin and bacitracin export from cytoplasmic membrane [46, 99] . Orthologues of the YsaBC transporter in other members are regulated by an adjacent TCS. To search a respective cognate TCS for YsaBC, we searched the microbial signal transduction database (http:// mistdb. com) and found a neighbouring TCS with the name of KinG (serine kinase, UniProt: Q9CET8) and IIrG (RR), UniProt ID: Q9CET7 [100, 101] . Here, we propose that the YsaBC transporter may be regulated by this adjacent TCS. Further studies will be required to investigate the role of KinG and IIrG TCS in regulating the YsaBC transporter of L. lactis. The major pathogenic bacteria encountring AMPs utilizing both the ABC transporters and TCS are summarized in Fig. 4 .
Proposed mechanism of action for BceAB-like transporters
The BceAB ABC transporters provide a substrate transport pathway across the membrane. Such paths are assisted by a cavity-based channel located at the dimer interface [102] . Among the ten TMHs the last four including larger ECL are topologically similar to MacB thus suggested to be of similar functional model [39, 103] . Structures of ABC transporters suggest an alternating ATP-dependent conformational scheme [104, 105] where the NBDs mediate the TMDs to shuffle between 'inward open' and 'outward open' states thus allowing the substrate (ATP or external substrate) to be coupled at one side of the membrane and free the other [103] . Upon ATP binding the NBD promotes conformational communication to the TMDs through a conserved helix [106] . This results in conformational change in the TMD and favours an 'outward-open' state and releases the substrate on the distal side of the membrane [103] . Further, ATP hydrolysis again cycles the transporter to an inward-facing conformation and favours another ATP to bind [107] . Apart from the conformational changes, the transmembrane proton electrochemical gradient may also further assist [108] . Contrary to this, Perez and Locher have proposed the outward-facing state only [104, 109] . Due to the variety of structural organizations and substrates it is expected that ABC transporters may rely on a variety of approaches [104] .
Role of an exceptional lanFEg-type transporter in resistance in Clostridium difficile
A major nosocomial pathogen, C. difficile is involved in severe intestinal diseases due to its ability to effectively neutralize the host immune response [110] . C. difficile carries strong resistance to a number of cationic AMPs produced by the host immune system and also nisin, gallidermin and polymyxin B by overexpressing its resistance-related genes [111, 112] . The CprABC transporter belongs to the LanFEGtype transporter containing two permease domains, each of which has six transmembrane helices and one ATPase domain. The predicted orphan histidine kinase (cprK) and its upstream cprABC ABC transporter encode potential mediators of the resistance [3] . In the presence of cationic AMPs, high induction of CprABC by CprK SK has been shown. Moreover, all the resistant mutant strains exhibited W235C/S230Y mutations in the predicted kinase phosphate and protein interaction region of SK. On the other hand, CprABC is shown to be responsible for nisin and gallidermin but not for polymyxin B resistance. Thus it is expected that CprK SK may also regulate some other candidate genes to mediate polymyxin B resistance. However, it is still elusive how CprK SK regulates CprABC in the absence of a second partner RR. The C. difficile genome encodes 51 RRs but most of them have not been characterized. The system is similar to lantibiotic immunity system of bacteria where a particular kind of lantibiotic is ribosomally synthesized (e.g. nisin) and is exported to outside environment [113] [114] [115] . Despite the similarity to the lantibiotic immunity system, the CprK SK and CprABC transporter has no reported data of involvement in lantibiotic production [113] .
ABC transporters regulated by the one-component system (OCs)
Enterococcus faecalis
In E. faecalis bacitracin-resistant operon bcrABD exhibits ABC transporter bcrAB located adjacent to the BcrR RR. BcrA serves as ATP-binding domain whereas BcrB is a membrane spanning domain with homology to BcrAB of B. licheniformis. In E. faecalis the ABC transporter BcrAB is regulated by a OCS containing a membrane anchored protein BcrR. Like the DNA-binding protein, N-terminus of BcrR consists of helix-turn-helix (HTH) while the C-terminus contains four predicted transmembrane helices [116, 117] . E. faecalis has 17 TCSs and 158 one-component signal transduction systems where both the SK and RR function is served by a single molecule [118, 119] . The BcrR, of the OCS, alone senses the presence of bacitracin and activates bcrABD operon, which in turn confers the high level of bacitracin resistance (HLBR) in E. faecalis [120] . Membrane-anchored BcrR has the ability to bind with the bcrAB promoter and regulate expression. The promoter region of the transporter contains inverted repeats 5′-GACA-N7-TGTC-3' , which are required for BcrR binding [116, 120] . The BcrR without the transmembrane domain was unable to bind bcrAB suggesting that the presence of promoter-inverted repeats are not sufficient for binding and the localized membrane helices are pivotal in regulating the bacitracin-resistant transporter. However, it is hard to understand how a membrane-anchored RR binds DNA to regulate gene expression. The DNA binding of BcrR is independent of bacitracin indicating that the bcrAB promoter is constitutively occupied by BcrR RR, which may be important for membrane-bound transcription factors.
Clostridium perfringens
C. perfringens is a Gram-positive anaerobic pathogenic bacterium in animals, which has phenotypic resistance to bacitracin [121] . Recently, putative bacterial efflux pump genes bcrAB (ABC transporter) were identified and characterized in isolated strains, from broiler chickens and turkey. The ABC transporter BcrAB, which is regulated by OCS BcrR in bcrABD operon, has the ability to mediate bacitracin transport across the membrane. In the presence of efflux pump inhibitor thioridazine, bacitracin susceptibility was significantly increased [122] .
Bacterial self-resistance
Peptide antibiotics are produced by bacteria and exported to outside environment by ABC transporter therefore bacteria need effective protection systems against their own products. Self-resistance against such antibiotics by producers is often assisted by ABC transporters, collectively termed as LanFEG, comprising of two membrane-spanning subunits and one ATPase domain [123, 124] . lanFEG expression is regulated by a TCS mostly present in the same genetic cluster [32] . Bacteria utilize two major mechanisms for self-protection, e.g. by LanFEG ABC transporter or by LanI immunity protein/LanH novel immunity protein. The necessity of immunity protein of lantibiotic producer for the self-protection system is still elusive but in comparison, the immunity level of the LanFEG system is much higher and effective than LanI [34] . The presence of both immunity proteins and ABC transporters is not required for lantibiotic self-resistances, for instance, the epidermin and mersacidin producers contain only LanFEG ABC transporter whereas the Pep5, apicidin and lactocin biosynthetic loci have LanI [32, 125] .
self-resistance by ABC transporters
The self-resistance is primarily assisted by ABC transporter LanFEG. The expression of lanFEG decreases accumulation of antibiotics inside the cell as compared to non-lanFEG expressing cells, suggesting lantibiotic transport to extracellular space [126, 127] . The LanFEG system also confers self-resistance to nisin, subtilin, lacticin-481, salivaricin A2, mersacidin, mutacin II and epidermin. Mersacidin, epidermin and lacticin-481 inhibit cell-wall biosynthesis by binding to lipid-II (cell-wall precursor). Normally, the lantibiotic biosynthetic, regulatory and accessory genes are organized into one chromosomal locus. Mersacidin biosynthetic locus contains genes for TCS mrsR2 (RR), mrsK2 (serine kinase) and an extra RR gene, mrsR, which is shown to control mersacidin production. MrsR2 and MrsK2 TCS mediates a self-protection by regulating ABC transporter genes mrsFEG. The biosynthetic operon of the lacticin-481 contains lctFEG ABC transporter genes, but not the TCS genes [23, 35-37, 128, 129] . The XRE family regulator ltnR, regulates lacticin sensitivity [130] . The ABC transporter EpiFEG for epidermin is regulated by a single RR gene only, EpiQ [128] . Similarly, MutR in mutacin II, LtnR in lacticin 3147, MrsR1 in mersacidin are all deficient of the serine kinase domain [35, 130, 131] .
The self-protection from mersacidin is only mediated by MrsFEG. However, different from epidermin, a pore-forming lantibiotic gallidermin is assisted by an accessory genes epiH and gdmH (exhibiting six transmembrane helices) [35, 132] . The accessory proteins EpiH and GdmH were shown to play a role in lantibiotic secretion instead of the immunity gene LanI (NisI and SpaI). The ABC transporter NisFEG removes nisin from the cytoplasmic membrane to the outside environment without modification or degradation 1 [132] .
self-resistance by immunity proteins
Bacteria prevent lantibiotics from binding to their target molecules like cell-wall precursors lipid-II. An immunity protein LanI intercepts antibiotics to form a membrane pore formation [3, 133] . LanI system protects bacteria from various kinds of peptide antibiotics like Pep5, apicidin 280 and lactocin S [127] . Similarly, NisI (nisin immunity protein) is attached to the membrane surface through lipid-modified cysteine residue at the N-terminus [134] . In subtilin and nisinproducing bacteria, the N-terminal signal sequence of LanI is removed by post-translational modifications and confined to the extracellular space. Both SpaI (subtilin immunity) and NisI (nisin immunity) are bound to their respective substrates to prevent cell-wall precursor lipid-II. The expression of immunity gene (lanI) or ABC transporter (lanFEG) exhibits a comparatively distinct level of protection, suggesting that both the systems can also work independently [27, 126] .
Almost three quarters of ABC transporters involved in selfresistance or protection are associated with a TCS. The major TCS in the regulation of LanFEG transporters belong to the EnvZ-like subgroup of kinases with periplasmic sensing domains. Subtilin and nisin self-protections and their regulatory TCS LanRK, e.g. SpaRK and NisRK are well reported. It has been shown that stimulus for peptide antibiotic is detected by the extracellular loop of SK with high specificity and sensitivity. The N-terminus of the LanK SK contains two hydrophobic transmembrane helices and an extra-cytoplasmic loop of more than 100 residues. The presence of lantibiotic molecule in extracellular environment is sensed by the extracytoplasmic loop of LanK followed by the transmission of signal to LanR, which binds the respective promoters and induces the expression of the lanFEG promoter, biosynthetic and immunity gene lanI [114, 135] .
self-resistance by lanH protein
The self-resistance to nukacin ISK-1 and lacticin-481 is achieved by LanFEG and LanH. Lantibiotic immunity protein LanH contains three transmembrane domains, for instance, RumH of Ruminococcus gnavus E1 and ORF4 of Butyrivibrio fibrisolvens OR79 [136, 137] . LanH is smaller as compared to LanI and located at the cytoplasmic membrane, whereas LanI is attached to the outer side of the membrane. Regarding substrate specificity, LanI is more specific as compared to LanH. NukH and ABC transporter NukFEG confer high immunity as compared to each of them [127] . The NukH captures the ISK-I by recognizing its C-terminus for a possible inactivation and transportation module by NukFEG [31] .
A mutation in a conserved E-loop of the LanF ATPase domain (E158Q) made no significant decrease in the immunity level as compared to non-conserved mutations E85A, which severely impaired LanF immunity function. ATPase activities of the purified mutants, E85Q and E85A were not disturbed suggesting that the E-loop found in ABC transporters is involved in immunity and transport functions [34] . Similar results were also reported for DrrA and DrrB. Functionally both the Q-and E-loops of NBD (DrrA) might be compliment to one another and play a significant role in the transport of doxorubicin and daunorubicin. The N-terminal cytoplasmic tail of DrrB interacts with the Q-loop of DrrA, indicating a conformational change in Q-/E-loop, which may reduce the immunity function of transporters [138, 139] .
ImmunE mImICRy
Immune mimicry is a newly identified mechanism in which non-lantibiotic bacteria encode the functional homologues of lantibiotic immunity system for self-resistance. The immune mimicry was first reported in B. licheniformis DSM13 and E. faecium DO, which resists lacticin 3147 [140] . Similarly, the nisin family homologue of nisin U immunity provides NusFEG within the genome of non-lantibiotic bacteria S. infantarius [141] .
lAntIBIOtIC tRAnsPORt
TCSs and adjacent ABC transporters are not limited to lantibiotic resistance and auto immunity. These two partners also participate in the production of ribosomally synthesized AMPs. In order to protect themselves from their products, Gram-negative and Gram-positive bacteria produce antimicrobial compounds active against closely related strains [12, 31] . The biosynthetic operons in bacteria, for peptide antibiotics, such as subtilin, nisin, mersacidin and bacitracin are connected with genes encoding efflux transporters of the ABC family, which pumps out these lantibiotics to the outside environment in self-protection [32, 142, 143] . Peptide antibiotics are synthesized ribosomally in the form of a precursor peptide or pre-peptides and are grouped into two classes I and II. These precursor peptides consist of an N-terminal leader sequence and a C-terminus pro-peptide domain. All these precursor peptides undergo post-translational modification into an active lantibiotic [32, 124] . The N-terminal leader peptide is involved in specifying the process of modification and targeting of pre-peptide [144] . Class-I peptide antibiotics (nisin, subtilin and epidermin) are modified post-translationally by LanB and LanC. LanB dehydrates serine and threonine residues in the precursor peptide yielding 2, 3-didehydroalanine and 2, 3-didehydrobutyrine. Dehydrated pre-peptide is further modified by the cyclase LanC, which catalyses the condensation of dehydrated residues to C-terminuspositioned cysteine residues and forms methyl-lanthionine rings [145] . The modified peptide precursor is secreted to the outside environment by the ABC-type transporter LanT in inactive form. To make it fully active the leader sequences is cleaved off by the cell-membrane-anchored protease NisP (Fig. 5 ) [144] . Class-II peptide antibiotics (lacticin 481 or mersacidin) are post-translationally modified and catalysed by a single enzyme LanM. Several biosynthetic loci harbour precursor, immunity, ABC transporter and TCS genes and enzymes that catalyse the modification reaction. Lantibiotics produced by such biosynthetic clusters as a result of strict interplay between TCS and secreted peptides serve as a signal to induce their own biosynthesis [146] . Different biosynthetic clusters and their regulation is reviewed in detail elsewhere [147] .
In the context of the nisin biosynthesis, once the nisin is exported to the extracellular environment, it acts as a pheromone peptide and induces its production through TCS NisRK [114, 148, 149] . The extracellular antibiotic, like nisin, is recognized by NisRK TCS and is sensed by the transmembrane domain of NisK, which in turn activates its cognate RR NisR inducing the transcription of target regulons nisA and the immunity and modification genes [3] . To ensure self-immunity, nisR promoter transcribes the TCS and NisP in a constitutive manner [37] . LanT encoded by antibiotic biosynthetic gene clusters is responsible to transport both the pre and matured antibiotic to the outside environment [147] . The mutant ABC transporter strains failed to transport nisin outside of the vicinity resulting in accumulation of nisin inside the cell [38, 150] . LanT peptides are not specific to its substrate and it seems that they recognize and bind the leader peptide to form a multimeric complex of LanB, LanC and LanT [151, 152] . However, the complex formation is not necessary for the transport of NisBT complex, which transport the thioether ring deficient pre-nisin. NisT alone can export unmodified pre-nisin by recognizing only the leader peptide [153] . Two thirds of lantibiotic biosynthetic clusters maintained a protease gene lanP in the neighbourhood of ABC transporter lanT, which cleaves the leader peptide and brings lantibiotic into a functional state. Some LanT-type transporter contained an extra N-terminal peptidase domain responsible for the processing of pre-peptides [153, 154] .
substrate specificty of BceAB-type transporter nsrFP
Recently, different groups have reported the expression of NSR operon in L. lactis with 20-fold resistance against nisin [155, 156] . To investigate the substrate specificity two different nisin variants, lacking the C-terminus lanthionine rings were tested in the nisin-sensitive strains. Both C-terminal deletion variants displayed fivefold increased resistance compared to the wild-type, suggesting that the N-terminal region of nisin is sufficient for recognition and to induce the NsrFP transporter. Apart from nisin, nisin H and gallidermin containing a similar N-terminus region to nisin with different structure were able to induce the NsrFP further strengthened the notion that such transporters identify the N-terminal region of lantibiotics [157] .
COnCludIng REmARks
Bacteria have developed innate and acquired resistances to the toxic compounds. The innate resistance is generally found in peptide antibiotic producing bacterial strains by which they expel the antibiotic to extracellular environment and protect themselves. In the acquired resistance, bacteria have developed a protection mechanism by evolving their genomes. Both resistances depend on the antibiotic transporting machinery and its specific regulation. Transport machinery comprised of ABC transporters regulated by TCS or OCS, which extrude the antibiotics out of the cell.
The presence of external antibiotics is sensed by the twocomponent regulatory system, which induces the transcription of ABC transporter genes. TCS components carry transmembrane or extracellular domains to sense specific antibiotics. Similarly ABC transporters are able to sense antibiotics through their extracellular loops. Antibiotic sensing mechanism is not yet established therefore more study is needed to understand the antibiotics sensing mechanism. What is the basis of sensing to distinguish between two structurally related antibiotics? How does LanFEG bind substrate antibiotics like BceAB-type transporters do? How does the EC loop of BceAB transporters sense the substrate? How does the BraDE transporter only accomplish sensing, leaving detoxification to VraDE? Further study will be required to evaluate the role of the EC loop of transporters along with IMSK SK as both can sense antibiotics. Future research will be an important concern in the field of antibiotic resistance to understand AMP sensing and transporting in bacteria.
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